On March 9, 2021 the Department of Health and Human Services (HHS) issued a proposal to further delay implementation of the Trump Administration’s final rule that would require federally qualified health centers (FQHCs) to provide insulin and injectable epinephrine to low-income patients at the price the FQHC pays for those drugs under the 340B program. …
Express Scripts, a large US-based PBM, announced a new 340B retrospective claims identification requirement. The new policy may impose significant burdens on 340B pharmacies and threaten the viability of safety net providers. On February 24, Express Scripts, one of the largest pharmacy benefit managers (PBMs) in the United States, issued a notice stating that, beginning March 1, pharmacies…
In a letter, led by Representatives Spanberger, Axne, Matsui, McKinley, sent to Acting HHS Secretary Norris Cochran, 226 Members of Congress called on HHS to take immediate action against manufacturers that refuse to provide discounted drugs to community safety net providers and require manufacturers to reimburse community safety net providers for overcharges. The also called on HHS…
Last week, prominent leaders in the Black community in New York sent a letter to state officials urging them to not move forward with a change in the Medicaid program that could needlessly harm the New Yorker’s access to 340B services. Last year, New York’s state budget included a provision that would require the New…
The deadline for members of the House of Representatives to back a bipartisan sign-on letter in support of the 340B program has been extended to February 25. Members of the House of Representatives – Spanberger (D-VA), Axne (D-IA), McKinley (R-WV), Johnson (R-SD), Katko (R-NY), and Matsui (D-CA) – are circulating the letter, which calls for HHS…
Next week, the Senate Committee on Health, Education, Labor and Pensions (February 23) and the Senate Finance Committee (February 24), will hold hearings with Xavier Becerra, President Biden’s nominee to lead the Department of Health and Human Services (HHS). The Senate Finance committee will either reject the nomination or approve the nomination and send it…
This week, Representatives Spanberger (D-VA), Axne (D-IA), McKinley (R-WV), Johnson (R-SD), Katko (R-NY), and Matsui (D-CA) began circulating a bipartisan sign-on letter that calls on Health and Human Services (HHS) Secretary nominee, Xavier Becerra, to address drug manufacturers’ refusal to provide 340B drug discounts to covered entities utilizing contract pharmacy arrangements. RWC-340B was a key…
While many families are directly impacted by COVID-19 and while frontline 340B safety-net providers – certain hospitals and clinics that serve low-income patients and communities – are fighting COVID-19 – Eli Lilly is reporting record profits tied directly to their actions to limit savings for diabetes medications to 340B safety net providers. Eli Lilly 2020…
In a flurry of executive orders and other Federal Register publications, the Biden Administration has revoked several policies of the prior administration that many 340B community members viewed as having been harmful to safety-net providers and their patients. For example, the Biden Administration issued a regulator freeze, which called on the heads of executive departments and…
In an op-ed submitted to the South Dade News Leader, Florida state Rep. Debbie Mucarsel-Powell announces her support of the 340B program and pledges to fight to protect it. The 340B program is one of the most important sources of affordable, critical care for the residents of South Florida. In her op-ed, Rep. Mucarsel-Powell states:…